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Visceral leishmaniasis remains a serious public health problem in developing countries. Cytokines have a crucial
role in the pathogenesis of this disease. We evaluated plasma levels of IL-10, IL-12 and IFN-γ in 32 patients with
active visceral lieshmaniasis, in 29 siblings of the patients and in 23 normal individuals in an endemic area to look
for correlations between the clinical outcome of infection and the plasma cytokine levels. An analysis was made
with a skin test and a quantitative sandwich enzyme immunoassay. Data were analyzed with the Mann Whitney test
and the Kruskal Wallis test. The cytokine levels were significantly higher in the patients than in the control groups.
We concluded that normalization of the plasma level of IFN-γ can serve as a reliable parameter for considering the
patient as cured.
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Visceral leishmaniasis (VL), also known as Kalaazar, is an
important health problem in developing countries and is
endemic in theMiddle East and Mediterranean regions [1,2].
Northwestern and southern Iran are focal regions for VL, which
mainly affects children; consequently, Leishmania infantum
is expected to be the dominant type of leishmania in Iran [3,4].
This disease can be asymptomatic, subclinical and self limiting
or can develop into clinically manifesting disease [5,6].
The factors that determine the development or not of VL
have not yet been completely identified, but a leishmania
specific cellular immune response seems to play a fundamental
role in the control of infection [7,8]. We know that resistance
to disease in VL is determined by an appropriate type 1
response, whereas susceptibility is mediated by a type 2
response, characterized by the stimulation of high titers of
antibody production [9]. In VL, susceptibility is associated
with an inability to produce a macrophage – stimulating
cytokine profile (Th1 profile), including interferon gamma (IFN-
γ) and interleukin -12 (IL-12); instead, production of immuno-
suppressive cytokines, such as interleukin 10 (IL-10), (Th2
profile) is observed (10).
Few studies have examined the production of cytokines
in the families of patients and normal individuals in endemic
areas. We evaluated the plasma levels of INF-γ, IL-10, and IL-
12 in patients with VL and in their asymptomatic siblings in
order to determine if there was a correlation between the clinical
symptoms of the disease and cytokine production.
Material and Methods
All patients admitted with a diagnosis of VL in the
infectious disease ward of Nemazi hospital, Shiraz, Iran, were
categorized as Group I. Group I consisted of 32 cases newly
identified as VL patients, based on clinical manifestation of
kalaazar, such as anemia, hepatosplenomegally, fever, with a
positive bone marrow smear, or IFA (immunoflurescent
antibody) ≥1/128. Group II consisted of 29 asymptomatic
siblings of these patients living in the endemic area. Group III
consisted of 27 asymptomatic individuals from the same
endemic area with a positive leishmania skin test, as a control
group.
Leishmanin for the skin test was prepared by the Pasteur
Institute; 0.1 mL of a diluted solution was injected intradermally
into the extensor surface of both forearms; induration ≥ 5mm
48 h after injection indicated a positive leishmania skin test.
After diagnosis of VL in 32 cases, (Group I) a blood sample
(about 3 mL) was obtained from each patient before treatment;
serum samples were maintained at -70oC.
After the skin test, a blood sample was obtained from
Group III (control) individuals and the plasma was stored at -
20oC in the field and subsequently at -70oC c until tested. The
same procedure was used for siblings of the patients with VL.
Plasma levels of IL-10, IL-12, IFN-γ were titered by sandwich
ELISA (Biosource, USA), according to the manufacturer’s
protocol. The minimum titrable plasma level of these cytokines
is 1 picogram/mL, levels below that were considered as zero.
The results were analyzed by the Mann-Whitney test and the
Kruskal -Wallis test using SPSS software.
This study was approved by the Research Ethics
Committee of Shiraz medical university and all individuals
included in this project, or their legal guardians, signed an
informed consent form before enrollment.
Results
Among 32 patients admitted with a diagnosis of visceral
leishmaniasis, 19 cases were female and 13 were male. The IFA
was positive for 25 patients and 28 of them had a positive
bone marrow smear. The IFA titer was 1/250 for four patients
and 1/128 in 21 cases.
In three patients, IFA titer was 1/40 and the bone marrow
smears were positive for VL; while in four cases, the IFA titer
was 1/64 and the bone marrow smear was negative, but there
were clinical manifestations and recovery after treatment.
www.bjid.com.br
BJID 2009; 13 (February) 4 5
The levels of cytokines in the patient group and in their
family are shown in Table 1. The serum levels of IFN-γ and IL-
12 in patients were significantly higher than those of their
siblings (Mann Whitney test, p<0.05, Table 1). The IL-10 levels
were also higher in patients than in the sibling group, but the
difference was not quite significant (p = 0.052).
When we compared the cytokine levels of all three groups
with the Kruskal Wallis test (Table 2), the levels of the
cytokines differed significantly. Patients had the highest levels,
followed by siblings; the control group had the lowest levels.
Discussion
In VL, development of disease and control of infection
depend on the effectiveness of an IFN-γ-induced innate and
adaptive cellular immune response, which affects the killing
of infected cells by active macrophages [11]. Exposure of
humans to Leishmania donovani or Leishmania infantum
can lead to either subclinical infection or overt visceral
leishmaniasis, which may become life threatening. Subclinical
infections are believed to be asymptomatic [12].
In our study, the levels of the serum cytokines, IL-10, IL-
12, and IFN-γ, were higher in patients than in family members
and control individuals.
The family group included individuals who had contact
with the parasite but had no clinical manifestations. Therefore
individuals with clinical manifestations had higher levels of
cytokines.
In a study in south-western Ethiopia, serum cytokines
(IFN-γ, IL-12, and IL-15) in 70 symptomatic VL patients were
significantly higher than in 39 patients with asymptomatic
leishmania infection and 12 healthy controls in the same
endemic area [13].
Our data confirm previous reports that during active
human VL there is an abundant production of several
cytokines [13-17].
In a study in Brazil, serum cytokine levels were determined
in subclinical or asymptomatic cases and lower levels of IL-10
and TNF-α were observed when compared to symptomatic
patients [18]. In another study, plasma IFN-γ levels were
elevated during active disease, reaching 470.2 ±143.4 pg/mL,
whereas normal individuals from the same endemic area
exhibited levels of 15.4±3.8. Plasma levels of IL-10 were elevated
during active disease, whereas they were undetectable in normal
individuals from the same endemic area [19].
IFN-γ has been reported to stimulate macrophage
leishmanicidal activity [17,20,21]; however, high serum levels
are found during active cases of VL with large parasite
burdens. IFN-γ in sera from active VL patients did not show
anti-leishmanal activity, though it has been reported in sera of
patients with tegumentary leishmaniasis and from recovered
VL patients [17].
Lack of IFN-γ activity may be related to the simultaneous
presence of elevated levels of IL-10, as IL-10 seems to be the
main macrophage-deactivating cytokine in human
leishmaniasis [22,23]. Previous investigations have shown that
in the plasma of VL patients, IFN-γ and other cytokines, such
as IL-10, IL-15, and TNF-α, are increased [24/; conversely,
decreased plasma concentrations of IFN-γ in Indian [16] and
IL-10, IL-12, and IFN-γ Levels in Visceral Leishmaniasis Patients
Table 1. Cytokine plasma levels in visceral leishmaniasis patients and family members.
Cytokine Number p value Mean +SD
IFN-γ in patients pg/mL 32 0.006 37.6±64.6
IFN-γ in family 29 5.9±14.8
IL-10 in patients ng/mL 32 0.052 77.5±88.3
IL-10 in family 29 55.9±100.4
IL-12 in patients ng/mL 32 0.001 798.3±639.8
IL-12 in family 29 271±178.5
Table 2. Cytokine plasma levels in visceral leishmaniasis patients, family and controls.
Cytokine Number Mean ± SD p value
IFN-γ in patient group 32 37.6±64.6
IFN-γ in family group 29 5.9±14.8 0.001
IFN-γ in control group 27 0.18±0.49
IL-10 in patient group 32 77.5±88.3 0.002
IL-10 in family group 29 55.9±100.4
IL-10 in control group 27 17.7±25.4
IL-12 in patient 32 798.3±639.8
IL-12 in family group 29 271.9±178.5 0.001
IL-12 in control group 27 216.9±169.4
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Brazilian [25] VL patients have been reported. The low levels
of IL-10 that we found in asymptomatic patients in an endemic
area when compared to patients indicates control of parasite
growth, lending support to an important role of this cytokine
in human VL. Also, the low levels of IL-10, IFN-γ and IL-12 in
healthy siblings of patients with VL corresponds to an
intermediate position between disease and protective
immunity. We found a marked reduction in plasma levels of
IFN-ã in the control group; therefore, normalization of the
plasma levels of IFN-γ could serve as a reliable parameter in
considering the patients cured.
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